Affordable Growth. Analyze the stocks which are showing good growth, decent profitability and health and are not overvalued from a fundamental perspective.
Overall HRMY gets a fundamental rating of 8 out of 10. We evaluated HRMY against 198 industry peers in the Pharmaceuticals industry. Both the health and profitability get an excellent rating, making HRMY a very profitable company, without any liquidiy or solvency issues. HRMY is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, HRMY could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year HRMY was profitable.
HRMY had a positive operating cash flow in the past year.
HRMY had positive earnings in 4 of the past 5 years.
HRMY had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 14.56%, HRMY belongs to the top of the industry, outperforming 95.96% of the companies in the same industry.
The Return On Equity of HRMY (22.07%) is better than 92.93% of its industry peers.
With an excellent Return On Invested Capital value of 18.94%, HRMY belongs to the best of the industry, outperforming 93.43% of the companies in the same industry.
HRMY had an Average Return On Invested Capital over the past 3 years of 18.27%. This is significantly below the industry average of 41.62%.
The 3 year average ROIC (18.27%) for HRMY is below the current ROIC(18.94%), indicating increased profibility in the last year.
Industry Rank
Sector Rank
ROA
14.56%
ROE
22.07%
ROIC
18.94%
ROA(3y)19.12%
ROA(5y)10.08%
ROE(3y)31.57%
ROE(5y)9.53%
ROIC(3y)18.27%
ROIC(5y)15.29%
1.3 Margins
HRMY has a Profit Margin of 20.36%. This is amongst the best in the industry. HRMY outperforms 92.42% of its industry peers.
HRMY's Profit Margin has improved in the last couple of years.
HRMY has a better Operating Margin (29.09%) than 93.43% of its industry peers.
In the last couple of years the Operating Margin of HRMY has declined.
HRMY has a Gross Margin of 78.06%. This is amongst the best in the industry. HRMY outperforms 84.34% of its industry peers.
HRMY's Gross Margin has been stable in the last couple of years.
HRMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, HRMY has more shares outstanding
Compared to 5 years ago, HRMY has less shares outstanding
The debt/assets ratio for HRMY has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.96 indicates that HRMY is not in any danger for bankruptcy at the moment.
The Altman-Z score of HRMY (4.96) is better than 81.82% of its industry peers.
HRMY has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.82, HRMY belongs to the best of the industry, outperforming 94.95% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that HRMY is not too dependend on debt financing.
HRMY has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
Industry Rank
Sector Rank
Debt/Equity
0.25
Debt/FCF
0.82
Altman-Z
4.96
ROIC/WACC1.91
WACC9.91%
2.3 Liquidity
A Current Ratio of 3.31 indicates that HRMY has no problem at all paying its short term obligations.
HRMY has a Current ratio (3.31) which is comparable to the rest of the industry.
A Quick Ratio of 3.27 indicates that HRMY has no problem at all paying its short term obligations.
HRMY has a Quick ratio of 3.27. This is in the better half of the industry: HRMY outperforms 60.10% of its industry peers.